RESUMEN
OBJECTIVE: To evaluate the efficacy and effects of labeling equine umbilical cord blood (UCB)- and bone marrow (BM)-derived multipotent mesenchymal stromal cells (MSCs) with an ultrasmall superparamagnetic iron oxide (SPIO) contrast agent and the detection of labeled MSCs by use of MRI. SAMPLE: UCB MSCs from placental tissues of 5 foals and BM MSCs from 5 horses. PROCEDURES: UCB and BM MSC cultures were seeded in duplicate (5,000 cells/cm(2)). One duplicate was incubated with SPIO (50 µg/mL); the other was processed identically, but without SPIO. Mesenchymal stromal cells were expanded in triplicates for 5 passages and assessed for viability and proliferative capacity, labeling efficacy, and labeled cell proportion. For MRI detection, 5 × 10(6) labeled BM MSCs from passage 1 or 2 were injected into a collagenase-induced superficial digital flexor tendon defect of an equine cadaveric forelimb from 2 horses. RESULTS: For passages 1, 2, and 3, labeling efficacy and cell proportion for UCB MSCs (99.6% [range, 98.8% to 99.9%], 16.6% [range, 6.5% to 36.1%], and 1.0% [range, 0.4% to 2.8%], respectively) were significantly higher than for BM MSCs (99.2% [range, 97.8% to 99.7%], 4.5% [range, 1.6% to 11.8%], and 0.2% [range, 0.1% to 0.6%], respectively). Labeling was not detectable after passage 3. Viability of MSCs was not affected, but cell doubling time increased in labeled MSCs, compared with that of unlabeled MSCs. On MRI 3-D T2*-weighted fast gradient echo sequences, decreased signal intensity was observed for BM passage 1 MSCs. CONCLUSIONS AND CLINICAL RELEVANCE: Equine UCB and BM MSCs were labeled with SPIO at high efficiencies.
Asunto(s)
Medios de Contraste , Dextranos , Sangre Fetal/citología , Caballos/anatomía & histología , Nanopartículas de Magnetita , Células Madre Mesenquimatosas/citología , Animales , Cadáver , Femenino , Miembro Anterior , Caballos/sangre , Imagen por Resonancia Magnética , Placenta/citología , Embarazo , Pase Seriado/veterinariaRESUMEN
OBJECTIVE: To compare the effect of extracorporeal shock wave therapy (ESWT) on expression of fibroblast growth factor-7 (FGF-7), transforming growth factor-ß1 (TGF-ß1), insulin-like growth factor-1 (IGF-1), platelet-derived growth factor-A (PDGF), and vascular endothelial growth factor-A (VEGF) in skin with surgically created skin wounds and intact skin in horses. ANIMALS: 14 healthy horses. PROCEDURE: 8 horses were treated with ESWT at 6 locations along the neck at 36, 24, 12, 6, 2, or 1 hour prior to collection of full-thickness biopsy specimens from each location; a control specimen was collected from a sham-treated location. In 6 horses, 5 full-thickness wounds were created in each forelimb. Wounds in 1 forelimb/horse received ESWT immediately after creation and subsequently on days 7, 14, and 21; wounds in the contralateral forelimb remained untreated. Biopsy specimens were collected from 1 wound on each forelimb on days 7, 14, 21, 28, and 35. Expression levels of FGF-7, TGF-ß1, IGF-1, PDGF, and VEGF were assessed in tissue samples from the horses' necks and forelimbs. RESULTS: In surgically created wounds, ESWT treatment was associated with reduced TGF-ß1 expression, compared with expression in control wounds, during the entire study period. At 28 days following wound creation, IGF-1 expression was significantly increased for treated and untreated wounds, compared with findings on days 7, 14, 21, and 35. There was no significant effect of treatment on FGF-7, TGF-ß1, IGF-1, PDGF, or VEGF expression in intact skin. CONCLUSIONS AND CLINICAL RELEVANCE: Intervention with ESWT to suppress TGF-ß1 may decrease granulation tissue production, resulting in improved wound healing on the distal portion of horses' limbs.